UB Paderborn / Katalog / Suche / in CDI

First‐in‐Human Study of the Safety and Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection

American journal of transplantation, 2014-06, Vol.14 (6), p.1346-1355

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Transplantation proceedings, 2001-02, Vol.33 (1-2), p.1659-1660

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial

Transplantation, 1997-07, Vol.64 (2), p.274

1997

Link zum Volltext

Verfügbarkeit prüfen

Induction immunotherapy in heart transplantation with T10B9.1A-31 : A phase I study

The Journal of heart and lung transplantation, 1997-09, Vol.16 (9), p.913-916

1997

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

Transplantation proceedings, 1995-10, Vol.27 (5 Suppl 1), p.46-46

1995

Link zum Volltext

Verfügbarkeit prüfen

T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection

American journal of kidney diseases, 1989-11, Vol.14 (5 Suppl 2), p.61

1989

Link zum Volltext

Verfügbarkeit prüfen

Comparison of T10B9.1A-31 and OKT3 in treating acute renal allograft rejection

Transplantation proceedings, 1993-02, Vol.25 (1), p.543-545

1993

Link zum Volltext

Verfügbarkeit prüfen

Renal vein thrombosis presenting as renal mass

Urology (Ridgewood, N.J.), 1989-09, Vol.34 (3), p.164-167

1989

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

American journal of kidney diseases, 2003-02, Vol.41 (2), p.464-470

2003

Link zum Volltext

Verfügbarkeit prüfen

Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody

Transplantation proceedings, 1989-02, Vol.21 (1 Pt 2), p.1778-1784

1989

Link zum Volltext

Verfügbarkeit prüfen

Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients

Transplantation, 1992-01, Vol.53 (1), p.80

1992

Link zum Volltext

Verfügbarkeit prüfen

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

Transplantation, 2008-05, Vol.85 (9), p.1261

2008

Link zum Volltext

Verfügbarkeit prüfen

T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action

Clinical transplantation, 1996-12, Vol.10 (6 Pt 2), p.607-613

1996

Link zum Volltext

Verfügbarkeit prüfen

Treatment of acute rejection with anti-T-cell antigen receptor complex αβ (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody : results of a prospective randomized double-blind trial

Transplantation proceedings, 1991, Vol.23 (1), p.1062-1065

1991

Link zum Volltext

Verfügbarkeit prüfen

Direct neural inhibition of insulin secretion in response to systemic hypoglycemia

The American journal of physiology, 1976-04, Vol.230 (4), p.1090-1094

1976

Link zum Volltext

Verfügbarkeit prüfen

Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial

Transplantation proceedings, 1991-02, Vol.23 (1 Pt 2), p.1062-1065

1991

Link zum Volltext

Verfügbarkeit prüfen

Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection

Transplantation proceedings, 1993-02, Vol.25 (1 Pt 1), p.543-545

1993

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

Transplantation proceedings, 1901-01, Vol.27 (5), p.46-46

1901

Link zum Volltext

Verfügbarkeit prüfen

Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells

PloS one, 2017-02, Vol.12 (2), p.e0172037-e0172037

2017

Link zum Volltext

Verfügbarkeit prüfen

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor

The journal of clinical endocrinology and metabolism, 2019-09, Vol.104 (9), p.4127-4142

2019

Link zum Volltext

Verfügbarkeit prüfen

Higher fish but lower micronutrient intakes: Temporal changes in fish consumption from capture fisheries and aquaculture in Bangladesh

PloS one, 2017-04, Vol.12 (4), p.e0175098-e0175098

2017

Link zum Volltext

Verfügbarkeit prüfen

Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial

The American journal of psychiatry, 1999-11, Vol.156 (11), p.1758-1764

1999

Link zum Volltext

Verfügbarkeit prüfen

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial

Kidney international, 2011-04, Vol.79 (8), p.897-907

2011

Link zum Volltext

Verfügbarkeit prüfen

CD40‐mediated signalling influences trafficking, T‐cell receptor expression, and T‐cell pathogenesis, in the NOD model of type 1 diabetes

Immunology, 2017-10, Vol.152 (2), p.243-254

2017

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Blood Th40 cells Reflect Disease Progression and Are Controlled by Rituximab in Human Multiple Sclerosis

The Journal of immunology (1950), 2019-05, Vol.202 (1_Supplement), p.182-182.45

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

First‐in‐Human Study of the Safety and Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial

Induction immunotherapy in heart transplantation with T10B9.1A-31 : A phase I study

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection

Comparison of T10B9.1A-31 and OKT3 in treating acute renal allograft rejection

Renal vein thrombosis presenting as renal mass

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody

Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action

Treatment of acute rejection with anti-T-cell antigen receptor complex αβ (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody : results of a prospective randomized double-blind trial

Direct neural inhibition of insulin secretion in response to systemic hypoglycemia

Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial

Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor

Higher fish but lower micronutrient intakes: Temporal changes in fish consumption from capture fisheries and aquaculture in Bangladesh

Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial

CD40‐mediated signalling influences trafficking, T‐cell receptor expression, and T‐cell pathogenesis, in the NOD model of type 1 diabetes

Peripheral Blood Th40 cells Reflect Disease Progression and Are Controlled by Rituximab in Human Multiple Sclerosis

Suchergebnisse filtern